US98956P1021 - Common Stock
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033.
Zimmer Biomet receives FDA clearance for ROSA Shoulder System, the world's first robotic-assisted surgery system for shoulder replacement.
Zimmer Biomet (ZBH) declares $0.24/share quarterly dividend, in line with previous. Forward yield 0.77% Payable April 30; for shareholders of record March 29; e
Zimmer Biomet (ZBH) surpasses earnings and revenue estimates in Q4 2023.
Zimmer Biomet (ZBH) declares $0.24/share quarterly dividend, in line with previous. Forward yield 0.81% Payable Jan. 31; for shareholders of record Dec. 27; ex-
MedTech stocks rally after Novo Nordisk (NVO) disappoints with Phase 3 cardiovascular data for its weight loss therapy, Wegovy. Read more here.
Zimmer Biomet (ZBH) shares slid 4% after the company lowered its 2023 revenue growth guidance. Read more here.
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.
Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners.
Although industry stalwarts don’t typically offer robust profitability potential, these high-growth S&P 500 stocks might change your tune.